For prostate cancer, one SD increase of NSUN4 expression was associated with 6% higher risk of cancer (OR: 1.06, 95% CI: 1.03–1.09, PSMR = 1.01 × 10−5). Here, NSUN4 is linked to prostate carcinoma.